TP53 and neoplasm: In five tumors (23.8%), only one potentially pathogenic/possibly pathogenic CGC, such as CDKN1B or KAT6B, which are considered to be TSGs (each one in a single tumor), was mutated, as was TP53 (in three different samples), which is considered to have a dual role gene, in accordance with CGC database (https://cancer.sanger.ac.uk/cosmic/census?tier=all#cl_search; accessed on 22 May 2020) [60] (Table 3).